As of 2026-04-22, the Relative Valuation of Cardiol Therapeutics Inc (CRDL.TO) is (7.26) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.05 CAD, the upside of Cardiol Therapeutics Inc based on Relative Valuation is -453.9%.
The range of the Relative Valuation is (5.97) - (7.58) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 21.6x | 17.5x |
| Forward P/E multiples | 14.8x - 18.8x | 18.5x |
| Fair Price | (5.97) - (7.58) | (7.26) |
| Upside | -391.0% - -469.6% | -453.9% |
| Date | P/E |
| 2026-04-20 | -5.09 |
| 2026-04-17 | -5.11 |
| 2026-04-16 | -4.74 |
| 2026-04-15 | -4.84 |
| 2026-04-14 | -4.76 |
| 2026-04-13 | -4.69 |
| 2026-04-10 | -4.79 |
| 2026-04-09 | -4.66 |
| 2026-04-08 | -4.44 |
| 2026-04-07 | -4.79 |
| 2026-04-06 | -4.81 |
| 2026-04-02 | -4.91 |
| 2026-04-01 | -4.84 |
| 2026-03-31 | -4.69 |
| 2026-03-30 | -4.24 |
| 2026-03-27 | -4.27 |
| 2026-03-26 | -3.80 |
| 2026-03-25 | -3.72 |
| 2026-03-24 | -3.60 |
| 2026-03-23 | -3.32 |
| 2026-03-20 | -3.20 |
| 2026-03-19 | -3.25 |
| 2026-03-18 | -3.32 |
| 2026-03-17 | -3.60 |
| 2026-03-16 | -3.62 |
| 2026-03-13 | -3.50 |
| 2026-03-12 | -3.55 |
| 2026-03-11 | -3.65 |
| 2026-03-10 | -3.55 |
| 2026-03-09 | -3.30 |
| 2026-03-06 | -3.23 |
| 2026-03-05 | -3.37 |
| 2026-03-04 | -3.47 |
| 2026-03-03 | -3.42 |
| 2026-03-02 | -3.50 |
| 2026-02-27 | -3.42 |
| 2026-02-26 | -3.60 |
| 2026-02-25 | -3.45 |
| 2026-02-24 | -3.40 |
| 2026-02-23 | -3.35 |
| 2026-02-20 | -3.45 |
| 2026-02-19 | -3.47 |
| 2026-02-18 | -3.60 |
| 2026-02-17 | -3.50 |
| 2026-02-13 | -3.47 |
| 2026-02-12 | -3.45 |
| 2026-02-11 | -3.60 |
| 2026-02-10 | -3.60 |
| 2026-02-09 | -3.55 |
| 2026-02-06 | -3.40 |